The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

The Tigers announced Friday that non-roster outfielder Akil Baddoo underwent surgery on Thursday to repair a fracture in his ...

Clear cell sarcoma is deemed highly aggressive due to its early tendency to metastasize, genetic mutations, and difficulty in ...

A fitness influencer was forced to have his have his lower jaw amputated after he was diagnosed with a rare form of oral ...

"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on ...

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...

Learn more about whether Penumbra, Inc. or Smith & Nephew plc is a better investment based on AAII's A+ Investor grades, ...

Learn more about whether Align Technology, Inc. or Smith & Nephew plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

to treat adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity, and to treat hypercalcemia ...

A distal femoral resection was required due to bone necrosis and persistence of the sepsis after wide-spectrum antibiotics and debridements. A temporary cement spacer was placed, and control of the ...